Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Shield Therapeutics Plc"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'22",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2022 is 200.00% vs -85.58% in Dec 2021",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2022 is -105.08% vs -657.69% in Dec 2021",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'22",
        "Dec'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.50",
          "val2": "1.50",
          "chgp": "200.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-24.00",
          "val2": "-18.20",
          "chgp": "-31.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.40",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-14.70",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-40.40",
          "val2": "-19.70",
          "chgp": "-105.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-5,911.30%",
          "val2": "-13,433.20%",
          "chgp": "752.19%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'22

Dec'22

Dec'21

Change(%)

Net Sales

4.50

1.50

200.00%

Operating Profit (PBDIT) excl Other Income

-24.00

-18.20

-31.87%

Interest

0.40

0.00

Exceptional Items

-14.70

0.00

Consolidate Net Profit

-40.40

-19.70

-105.08%

Operating Profit Margin (Excl OI)

-5,911.30%

-13,433.20%

752.19%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2022 is 200.00% vs -85.58% in Dec 2021

Consolidated Net Profit

YoY Growth in year ended Dec 2022 is -105.08% vs -657.69% in Dec 2021

All Annual Results